Responses
Chemotherapy
Treatment of Advanced or Recurrent Endometrial Carcinoma With Doxorubicin in Patients Progressing After Paclitaxel/Carboplatin: Memorial Sloan-Kettering Cancer Center Experience From 1995 to 2009
Compose a Response to This Article
Other responses
No responses have been published for this article.